ICH E6(R3) transformed computer system validation from IT documentation to mandatory GCP accountability.…
A practical guide to 21 CFR Part 11 compliance—covering electronic records, audit trails,…
How the draft PIC/S Annex 22 AI GMP guidance reshapes validation, oversight, and…
Australian pharmaceutical sponsors must maintain full TGA compliance throughout the December–January shutdown. This…
This article explains how to develop a compliant Australian-Specific Annexure (ASA) that aligns…
Navigating 2026 ICH E6(R3) Implementation in Australia: Your Quality Management Transformation Guide
Introduction When did your monitoring team last anticipate and prevent a protocol deviation?This…
The modern Australian QPPV in 2026 faces an environment transformed by AI, evolving…
Australia offers two pathways for clinical trials using unapproved therapeutic goods: the CTN…
AI in antimicrobial stewardship enhances surveillance, speeds evidence retrieval, and supports clinicians with…
AI in GxP is moving from theory to practice — but timing matters.…
Embedding ALCOA+ principles builds defensible, inspection-ready data integrity across regulated systems.
A confident pharmacovigilance contact person represents the modern face of drug safety—where AI-driven…